Cargando…

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles

Malaria is a highly prevalent parasitic disease in regions with tropical and subtropical climates worldwide. Among the species of Plasmodium causing human malaria, P. vivax is the second most prevalent and the most geographically widespread species. A major target of a pre-erythrocytic vaccine is th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gimenez, Alba Marina, Salman, Ahmed M., Marques, Rodolfo F., López-Camacho, César, Harrison, Kate, Kim, Young Chan, Janse, Chris J., Soares, Irene S., Reyes-Sandoval, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429696/ https://www.ncbi.nlm.nih.gov/pubmed/34504134 http://dx.doi.org/10.1038/s41598-021-96986-1

Ejemplares similares

Genotyping and Phylogenetic Analysis of Plasmodium vivax Circumsporozoite Protein (PvCSP) Gene of Clinical Isolates in South-Eastern Iran
por: ETEMADI, Soudabeh, et al.
Publicado: (2020)

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
por: de Camargo, Tarsila Mendes, et al.
Publicado: (2018)

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018)

Exploration of genetic diversity of Plasmodium vivax circumsporozoite protein (Pvcsp) and Plasmodium vivax sexual stage antigen (Pvs25) among North Indian isolates
por: Kaur, Hargobinder, et al.
Publicado: (2019)

Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers
por: Raza, Afsheen, et al.
Publicado: (2013)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017)

A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite
por: Lima, Luciana C., et al.
Publicado: (2020)

Plasmodium vivax pre-erythrocytic vaccines
por: Reyes-Sandoval, Arturo
Publicado: (2021)

Polyclonal Antibody Generation against PvTRAg for the Development of a Diagnostic Assay for Plasmodium vivax
por: Aggarwal, Shalini, et al.
Publicado: (2023)

Genetic characterization of Plasmodium vivax isolates from Pakistan using circumsporozoite protein (pvcsp) and merozoite surface protein-1 (pvmsp-1) genes as genetic markers
por: Bibi, Zainab, et al.
Publicado: (2021)

Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
por: Nateghpour, Mehdi, et al.
Publicado: (2021)

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon
por: Soares, Isabela Ferreira, et al.
Publicado: (2020)

Putative circumsporozoite protein (CSP) of Plasmodium vivax is considerably distinct from the well-known CSP and plays a role in the protein ubiquitination pathway
por: Dash, Manoswini, et al.
Publicado: (2019)

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
por: Atcheson, Erwan, et al.
Publicado: (2020)

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

Characterizing PvARP, a novel Plasmodium vivax antigen
por: Moreno-Pérez, Darwin A, et al.
Publicado: (2013)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
por: Kim, Young Chan, et al.
Publicado: (2020)

Antibody Responses Against Plasmodium vivax TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon
por: Matos, Ada da Silva, et al.
Publicado: (2019)

Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2
por: Perrotti, Edvige, et al.
Publicado: (2023)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
por: Marin-Mogollon, Catherin, et al.
Publicado: (2018)

PvRON2, a new Plasmodium vivax rhoptry neck antigen
por: Arévalo-Pinzón, Gabriela, et al.
Publicado: (2011)

Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium vivax
por: Lee, Seong-Kyun, et al.
Publicado: (2016)

Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
por: de Jong, Roos M., et al.
Publicado: (2019)

Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein
por: Marques, Rodolfo F., et al.
Publicado: (2020)

First imported relapse case of Plasmodium vivax malaria and analysis of its origin by CSP sequencing in Henan Province, China
por: Liu, Ying, et al.
Publicado: (2014)

Towards a Vaccine against Plasmodium vivax Malaria
por: Beeson, James G, et al.
Publicado: (2007)

Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4)
por: Arévalo-Pinzón, Gabriela, et al.
Publicado: (2013)

Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein
por: Cheng, Yang, et al.
Publicado: (2019)

Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180
por: Muh, Fauzi, et al.
Publicado: (2017)

PvP01-DB: computational structural and functional characterization of soluble proteome of PvP01 strain of Plasmodium vivax
por: Singh, Ankita, et al.
Publicado: (2020)

Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent
por: Prajapati, Surendra K, et al.
Publicado: (2006)

Allelic Variations of Plasmodium vivax Apical Membrane Antigen-1 (Pv AMA-1) in Malarious Areas of Southeastern Iran Using PCR-RFLP Technique
por: MOTEVALLI HAGHI, Afsaneh, et al.
Publicado: (2018)

Distinct Allelic Diversity of Plasmodium vivax Merozoite Surface Protein 3-Alpha (PvMSP-3α) Gene in Thailand Using PCR-RFLP
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2023)

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum
por: Beutler, Nathan, et al.
Publicado: (2022)

Methotrexate Is Highly Potent Against Pyrimethamine-Resistant Plasmodium vivax
por: Imwong, Mallika, et al.
Publicado: (2011)

Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1)
por: Moreno-Perez, Darwin A, et al.
Publicado: (2011)

First characterization of Plasmodium vivax liver stage antigen (PvLSA) using synthetic peptides
por: Goo, Youn-Kyoung, et al.
Publicado: (2014)

Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein
por: Cheng, Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5s298pplnr5jtb743eqv2t3l96